SARS-CoV-2 Antiviral Prescribing Gaps Among Nonhospitalized High-Risk Adults

Matthew E. Levy; Evanette Burrows; Vanessa Chilunda; Pamala A. Pawloski; Phillip R. Heaton; Joseph Grzymski; Jason D. Goldman; Lisa M. McEwen; Dana Wyman; Andrew Dei Rossi; Hang Dai; Magnus Isaksson; Nicole L. Washington; Tracy Basler; Kevin Tsan; Jason Nguyen; Jimmy Ramirez; Efren Sandoval; William Lee; James Lu; Shishi Luo

doi:10.1093/cid/ciad796

SARS-CoV-2 Antiviral Prescribing Gaps Among Nonhospitalized High-Risk Adults

Matthew E. Levy
, Evanette Burrows
, Vanessa Chilunda
, Pamala A. Pawloski
, Phillip R. Heaton
, Joseph Grzymski
, Jason D. Goldman
, Lisa M. McEwen
, Dana Wyman
, Andrew Dei Rossi
, Hang Dai
, Magnus Isaksson
, Nicole L. Washington
, Tracy Basler
, Kevin Tsan
, Jason Nguyen
, Jimmy Ramirez
, Efren Sandoval
, William Lee
, James Lu

Shishi Luo

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

Within a multistate clinical cohort, SARS-CoV-2 antiviral prescribing patterns were evaluated from April 2022-June 2023 among nonhospitalized patients with SARS-CoV-2 with risk factors for severe COVID-19. Among 3247 adults, only 31.9% were prescribed an antiviral agent (87.6% nirmatrelvir/ ritonavir, 11.9% molnupiravir, 0.5% remdesivir), highlighting the need to identify and address treatment barriers.

Original language	English
Pages (from-to)	1531-1535
Number of pages	5
Journal	Clinical Infectious Diseases
Volume	78
Issue number	6
DOIs	https://doi.org/10.1093/cid/ciad796
State	Published - 15 Jun 2024
Externally published	Yes

Keywords

SARS-CoV-2
antiviral agents
electronic health records
molnupiravir
nirmatrelvir

Access to Document

10.1093/cid/ciad796

Cite this

Levy, M. E., Burrows, E., Chilunda, V., Pawloski, P. A., Heaton, P. R., Grzymski, J., Goldman, J. D., McEwen, L. M., Wyman, D., Dei Rossi, A., Dai, H., Isaksson, M., Washington, N. L., Basler, T., Tsan, K., Nguyen, J., Ramirez, J., Sandoval, E., Lee, W., ... Luo, S. (2024). SARS-CoV-2 Antiviral Prescribing Gaps Among Nonhospitalized High-Risk Adults. Clinical Infectious Diseases, 78(6), 1531-1535. https://doi.org/10.1093/cid/ciad796

@article{30888c79c7a54422ae8f56e629f2d276,

title = "SARS-CoV-2 Antiviral Prescribing Gaps Among Nonhospitalized High-Risk Adults",

abstract = "Within a multistate clinical cohort, SARS-CoV-2 antiviral prescribing patterns were evaluated from April 2022-June 2023 among nonhospitalized patients with SARS-CoV-2 with risk factors for severe COVID-19. Among 3247 adults, only 31.9\% were prescribed an antiviral agent (87.6\% nirmatrelvir/ ritonavir, 11.9\% molnupiravir, 0.5\% remdesivir), highlighting the need to identify and address treatment barriers.",

keywords = "SARS-CoV-2, antiviral agents, electronic health records, molnupiravir, nirmatrelvir",

author = "Levy, \{Matthew E.\} and Evanette Burrows and Vanessa Chilunda and Pawloski, \{Pamala A.\} and Heaton, \{Phillip R.\} and Joseph Grzymski and Goldman, \{Jason D.\} and McEwen, \{Lisa M.\} and Dana Wyman and \{Dei Rossi\}, Andrew and Hang Dai and Magnus Isaksson and Washington, \{Nicole L.\} and Tracy Basler and Kevin Tsan and Jason Nguyen and Jimmy Ramirez and Efren Sandoval and William Lee and James Lu and Shishi Luo",

year = "2024",

month = jun,

day = "15",

doi = "10.1093/cid/ciad796",

language = "English",

volume = "78",

pages = "1531--1535",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "6",

}

Levy, ME, Burrows, E, Chilunda, V, Pawloski, PA, Heaton, PR, Grzymski, J, Goldman, JD, McEwen, LM, Wyman, D, Dei Rossi, A, Dai, H, Isaksson, M, Washington, NL, Basler, T, Tsan, K, Nguyen, J, Ramirez, J, Sandoval, E, Lee, W, Lu, J & Luo, S 2024, 'SARS-CoV-2 Antiviral Prescribing Gaps Among Nonhospitalized High-Risk Adults', Clinical Infectious Diseases, vol. 78, no. 6, pp. 1531-1535. https://doi.org/10.1093/cid/ciad796

TY - JOUR

T1 - SARS-CoV-2 Antiviral Prescribing Gaps Among Nonhospitalized High-Risk Adults

AU - Levy, Matthew E.

AU - Burrows, Evanette

AU - Chilunda, Vanessa

AU - Pawloski, Pamala A.

AU - Heaton, Phillip R.

AU - Grzymski, Joseph

AU - Goldman, Jason D.

AU - McEwen, Lisa M.

AU - Wyman, Dana

AU - Dei Rossi, Andrew

AU - Dai, Hang

AU - Isaksson, Magnus

AU - Washington, Nicole L.

AU - Basler, Tracy

AU - Tsan, Kevin

AU - Nguyen, Jason

AU - Ramirez, Jimmy

AU - Sandoval, Efren

AU - Lee, William

AU - Lu, James

AU - Luo, Shishi

PY - 2024/6/15

Y1 - 2024/6/15

N2 - Within a multistate clinical cohort, SARS-CoV-2 antiviral prescribing patterns were evaluated from April 2022-June 2023 among nonhospitalized patients with SARS-CoV-2 with risk factors for severe COVID-19. Among 3247 adults, only 31.9% were prescribed an antiviral agent (87.6% nirmatrelvir/ ritonavir, 11.9% molnupiravir, 0.5% remdesivir), highlighting the need to identify and address treatment barriers.

AB - Within a multistate clinical cohort, SARS-CoV-2 antiviral prescribing patterns were evaluated from April 2022-June 2023 among nonhospitalized patients with SARS-CoV-2 with risk factors for severe COVID-19. Among 3247 adults, only 31.9% were prescribed an antiviral agent (87.6% nirmatrelvir/ ritonavir, 11.9% molnupiravir, 0.5% remdesivir), highlighting the need to identify and address treatment barriers.

KW - SARS-CoV-2

KW - antiviral agents

KW - electronic health records

KW - molnupiravir

KW - nirmatrelvir

UR - https://www.scopus.com/pages/publications/85196218687

U2 - 10.1093/cid/ciad796

DO - 10.1093/cid/ciad796

M3 - Article

C2 - 38170452

AN - SCOPUS:85196218687

SN - 1058-4838

VL - 78

SP - 1531

EP - 1535

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 6

ER -

SARS-CoV-2 Antiviral Prescribing Gaps Among Nonhospitalized High-Risk Adults

Abstract

Keywords

Access to Document

Fingerprint

Cite this